Evening Shell.
My theory on why PTX gets to work with the best comes down to one word...OmniCar.
Simply put it has to be one of, if not the hottest property in CAR-T & more broadly cell therapy...It's very potentially the holy grail of cancer.
What professional or organisation in the cancer/cell therapy space wouldn't want the opportunity to collaborate on such a platform? For me it's a no brainer hence the BOD and SAB we've attracted.
Naturally having the right management & BOD is an integral part of attracting the right collaborations but the IP really is off the charts exciting.
Evening Shell. My theory on why PTX gets to work with the best...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
